Shots:
- Under the collaboration, the companies will jointly develop CDx solutions for the innovative assets which are being developed under I-Mab to accelerate the R&D process of innovative biologics with cutting-edge diagnosis and treatment technologies
- The collaboration will complement I-Mab’s efforts and accelerate the clinical R&D of its innovative pipeline with the addition of Roche Diagnostics’ CDx technology to provide transformative medicines for cancer patients globally and in China
- I-Mab plans to expands its global footprint beyond Shanghai (HQ), Beijing, Hangzhou, Guangzhou, Lishui, and Hong Kong in China & Maryland, San Diego (US)
Click here to read the full press release/ article | Ref: PR Newswire | Image: I-Mab
The post I-Mab Collaborates with Roche Diagnostics to Co-Develop CDx Solutions at the 4th CIIE (Shanghai) first appeared on PharmaShots.
